Market Research Logo

The US Testosterone Market Report: 2016 Edition

The US Testosterone Market Report: 2016 Edition

Testosterone industry is a prominent segment of the pharmaceutical industry. Testosterone is a steroid hormone which exerts effects on the males throughout life. Testosterone is significant for maintaining muscle bulk, adequate levels of red blood cells, bone growth, a sense of well-being, and sexual function. Low testosterone may result in decreased sex drive, erectile dysfunction, depression and loss of muscle mass. The testosterone level starts falling as the age of the person increases. Many other factors like injury or loss of testicles, chemotherapy, genetic abnormalities, chronic diseases and alcoholism may also result in low level of testosterone. Testosterone directly impacts the endocrine system, reproductive system, central nervous system and circulatory system of the body.

Testosterone replacement therapy is used for treating the low level of testosterone. Testosterone therapy is available in several forms like gels, patches, injections and oral testosterone tablets. There are various benefits associated with the therapy like an increased sex drive, increase muscle mass and an improved bone mineral density. However, studies have shown that high risk of cardiovascular diseases and prostate cancer after the testosterone therapy due to which FDA has issued regulations. Due to FDA regulations the market has suffered in the US because of the warning given through labeling done on the products but the market is coming back on track with the introduction of more efficient products. Key products like Androgel, Axiron and Otrexup are performing well in the market and many are pending for approval.

The key factors driving the growth of the market in the US are ageing population of the US, increasing healthcare expenditure per capita, decrease in fertility rate, increase in the US obese population and increased risk of developing hypogonadism. Some of the noteworthy trends and developments of this industry are introduction of oral testosterone pills and new drug, innovative gel technologies and testosterone therapy for women. However, the expansion of market can be affected by high risk of cardiovascular diseases, legal regulations and risk of prostate cancer.

The report “The US Testosterone Market” provides an in-depth analysis of the US testosterone market along with product analysis. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Acrux, Antares Pharma, AbbVie and Endo International are being profiled.


1. Testosterone Market – An Introduction
1.1 Testing Testosterone
1.2 Symptoms of Low Testosterone
1.3 Causes of Low Testosterone
1.4 Biological Uses of Testosterone
1.5. Hypogonadism
1.5.1 Types of Hypogonadism
1.5.2 Treatment Methods of Hypogonadism
2. Testosterone Replacement Therapy (TRT)
2.1 Benefits of Testosterone Therapy
2.2 Risk of Testosterone Therapy
3. The US Testosterone Market Analysis
3.1 The US Testosterone Market by Value
Table 1: The US Testosterone Market by Value (2013–2018E)
Table 2: Men Enrolled for Testosterone Therapy by Prior Prescriptions (2014)
3.2 The US Testosterone Prescriptions by Volume
Table 3: The US Testosterone Prescriptions by Volume (2012-2020E)
3.3 The US Testosterone Prescriptions Growth Rate
Table 4: The US Testosterone Prescriptions Growth Rate (2013-2020E)
3.4 Injectable Testosterone Prescriptions by Volume
Table 5: Injectable Testosterone Prescriptions by Volume (2012-2020E)
3.5 Injectable Testosterone Prescriptions Growth Rate
Table 6: Injectable Testosterone Prescriptions Growth Rate (2013-2020E)
3.6 Topical Testosterone Prescriptions by Volume
Table 7: Topical Testosterone Prescriptions by Volume (2012-2020E)
3.7 Topical Testosterone Prescriptions Growth Rate
Table 8: Topical Testosterone Prescriptions Growth Rate (2013-2020E)
3.8 Decreasing Testosterone Level of Men with Age
Table 9: Decreasing Testosterone Level of Men with Age
3.9 Patients Opting for Testosterone Therapy by Volume in the US
Table 10: Patients Opting for Testosterone Therapy by Volume in the US (2010-2015E)
Table 11: Male Patients Opting for Testosterone Therapy by Volume in the US (2010-2015E)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 The US Ageing Population
Table 12: The US Ageing Population (2007-2015E)
4.1.2 Increasing Healthcare Expenditure
Table 13: The US Healthcare Expenditure Per Capita (2007-2015E)
4.1.3 Decrease in Fertility Rate
Table 14: The US Fertility Rate (1970-2014)
4.1.4 Increase in Obese Population Rate
Table 15: The US Obese Population Growth Rate (2008-2014)
4.1.5 Increased Risk of Developing Hypogonadism
Table 16: Hypogonadism Prevalence in Percentage by Age Group
4.2 Trends and Developments
4.2.1 Introduction of Oral Testosterone Pill and New Drug
4.2.2 Innovative Gel Technologies and Convenient Treatment Options
4.2.3 Testosterone Therapy for Women
4.3 Challenges
4.3.1 High Risk of Cardiovascular Diseases
Table A: Heart Attack among Men before and after Testosterone Therapy (2014)
4.3.2 Legal Regulations
4.3.3 Risk of Prostate Cancer
5. Competitive Landscape
5.1 Testosterone Products - Market Share
Table B: Testosterone Products Market Share by Company (2012 -2019E)
5.2. Key Product Analysis
5.2.1 Vibex QuickShot Testosterone
Table C: Difference between Vibex Quickshot and Intramuscular Injection
Table 17: Vibex QS T Sales Estimations in the US (2018E-2022E)
5.2.2 OTREXUP
Table 18: Monthly TRX (Oral and Injectable Methotrexate)
Table D: Difference between Oral and Injectable Methotrexate
Table 19: OTREXUP Sales by Revenue in the US (2014-2019E)
5.2.3 LPCN 1021
Table 20: LPCN 1021 Estimated Sales by Revenue in the US (2016E–2025E)
5.2.4 Axiron
Table 21: Axiron Prescription Volumes (TRx) (2015)
5.2.5 Androgel
Table 22: Androgel Sales by Revenue in the US (2013-2015)
5.2.6 EpiPen
Table 23: Total EpiPen Prescriptions in the US (2014-2019E)
6. Company Profiles
6.1 Acrux
6.1.1 Business Overview
Table 24: Acrux Revenue by Products (2015)
Table 25: Acrux Revenue by Geography (2015)
6.1.2 Financial Overview
Table 26: Acrux Revenue and Net Income (2011-2015)
6.1.3 Business Strategies
6.2 Antares Pharma
6.2.1 Business Overview
Table 27: Antares Revenue by Segment (2015)
6.2.2 Financial Overview
Table 28: Antares Pharma Revenue and Net Income (2011-2015)
6.2.3 Business Strategies
6.3 AbbVie
6.3.1 Business Overview
Table 29: AbbVie Revenue by Products (2015)
Table 30: AbbVie Revenue by Geography (2015)
6.3.2 Financial Overview
Table 31: AbbVie Revenue and Net Income (2011-2015)
6.3.3 Business Strategies
6.4 Endo International Plc
6.4.1 Business Overview
Table 32: Endo’s Revenue by Segment (2015)
6.4.2 Financial Overview
Table 33: Endo International’s Revenue and Net Income (2011-2015)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report